153 related articles for article (PubMed ID: 10048911)
21. HIV-associated non-mycobacterial sepsis-bacteraemia, before and during the highly active antiretroviral therapy era.
Manfredi R; Nanetti A; Ferri M; Chiodo F
AIDS; 1999 Jul; 13(10):1274-6. PubMed ID: 10416534
[No Abstract] [Full Text] [Related]
22. HIV infection in children: what's new in 1996. Place of pulmonary complications.
Courpotin C
Pediatr Pulmonol Suppl; 1997; 16():190-1. PubMed ID: 9443269
[No Abstract] [Full Text] [Related]
23. [Bacterial pneumonia in HIV-infected patients (excluding mycobacterial infection)].
Godet C; Beraud G; Cadranel J
Rev Mal Respir; 2012 Oct; 29(8):1058-66. PubMed ID: 23101646
[TBL] [Abstract][Full Text] [Related]
24. Epidemiology of human immunodeficiency virus-associated pulmonary disease.
Murray JF
Clin Chest Med; 2013 Jun; 34(2):165-79. PubMed ID: 23702168
[TBL] [Abstract][Full Text] [Related]
25. Bacterial pneumonia, HIV therapy, and disease progression among HIV-infected women in the HIV epidemiologic research (HER) study.
Kohli R; Lo Y; Homel P; Flanigan TP; Gardner LI; Howard AA; Rompalo AM; Moskaleva G; Schuman P; Schoenbaum EE;
Clin Infect Dis; 2006 Jul; 43(1):90-8. PubMed ID: 16758423
[TBL] [Abstract][Full Text] [Related]
26. [Pathogenic role of Acinetobacter spp during HIV infection].
Manfredi R; Nanetti A; Valentini R; Chiodo F
Infez Med; 2001 Mar; 9(1):43-51. PubMed ID: 12082349
[TBL] [Abstract][Full Text] [Related]
27. I hear you knockin' (but you can't come in): potent new HIV therapies are shutting out opportunistic infections.
Fichtenbaum CJ
Res Initiat Treat Action; 1998 Jul; 4(4):3-7. PubMed ID: 11365645
[TBL] [Abstract][Full Text] [Related]
28. The impact of HIV infection and trimethoprim-sulphamethoxazole prophylaxis on bacterial isolates from children with community-acquired pneumonia in South Africa.
Zar HJ; Hanslo D; Hussey G
J Trop Pediatr; 2003 Apr; 49(2):78-83. PubMed ID: 12729288
[TBL] [Abstract][Full Text] [Related]
29. Bacterial pneumonia in HIV-infected patients: use of the pneumonia severity index and impact of current management on incidence, aetiology and outcome.
Curran A; Falcó V; Crespo M; Martinez X; Ribera E; Villar del Saz S; Imaz A; Coma E; Ferrer A; Pahissa A
HIV Med; 2008 Oct; 9(8):609-15. PubMed ID: 18557951
[TBL] [Abstract][Full Text] [Related]
30. Decline of infectious skin manifestations in the era of highly active antiretroviral therapy.
Hengge UR; Franz B; Goos M
AIDS; 2000 May; 14(8):1069-70. PubMed ID: 10853995
[No Abstract] [Full Text] [Related]
31. [Management of an epidemic of multidrug-resistant tuberculosis in patients with HIV infection in 2 hospitals of Milan].
Sodano L
Ann Ig; 2000; 12(4 Suppl 2):111-4. PubMed ID: 11100560
[No Abstract] [Full Text] [Related]
32. Altered natural history of AIDS-related opportunistic infections in the era of potent combination antiretroviral therapy.
Jacobson MA; French M
AIDS; 1998; 12 Suppl A():S157-63. PubMed ID: 9632998
[TBL] [Abstract][Full Text] [Related]
33. [Highly Active AntiRetroviral Therapy and opportunistic protozoan infections].
Pozio E
Parassitologia; 2004 Jun; 46(1-2):89-93. PubMed ID: 15305694
[TBL] [Abstract][Full Text] [Related]
34. Opportunistic infections in the era of highly active antiretroviral therapy.
Ferri RS
Lippincotts Prim Care Pract; 2000; 4(1):20-8. PubMed ID: 11022517
[No Abstract] [Full Text] [Related]
35. Immune reconstitution in several forms.
Ball SC
AIDS Read; 2005 Jan; 15(1):17-20. PubMed ID: 15685730
[No Abstract] [Full Text] [Related]
36. Effect of highly active antiretroviral therapy on recurrent oropharyngeal candidiasis in HIV-infected patients.
Revankar SG; Sanche SE; Dib OP; Caceres M; Patterson TF
AIDS; 1998 Dec; 12(18):2511-3. PubMed ID: 9875598
[No Abstract] [Full Text] [Related]
37. CURB-65 and other markers of illness severity in community-acquired pneumonia among HIV-positive patients.
Almeida A; Almeida AR; Castelo Branco S; Vesza Z; Pereira R
Int J STD AIDS; 2016 Oct; 27(11):998-1004. PubMed ID: 26394997
[TBL] [Abstract][Full Text] [Related]
38. [Incidence of bacterial pneumonia in HIV-positive patients treated with preventive co-trimoxazole or pentamidine].
Koch A; Kothe H; Braun J; Kämmerer R; Friedrich HJ; Dalhoff K
Pneumologie; 1998 Nov; 52(11):614-21. PubMed ID: 9885511
[TBL] [Abstract][Full Text] [Related]
39. Reduction of HIV-associated oral lesions after highly active antiretroviral therapy.
Aguirre JM; Echebarria MA; Ocina E; Ribacoba L; Montejo M
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1999 Aug; 88(2):114-5. PubMed ID: 10468448
[No Abstract] [Full Text] [Related]
40. Scenario of HIV/AIDS patients in a government hospital of Nepal.
Poudel BN; Dhungana GP
J Nepal Health Res Counc; 2010 Oct; 8(2):103-6. PubMed ID: 21876573
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
